Clinical and Experimental Pediatrics

The Korean Pediatric Society (대한소아청소년과학회)
권호 표지
DOI QR코드

DOI QR Code

Reality of Kawasaki disease epidemiology

  • Kim, Gi Beom (Department of Pediatrics, Seoul National University Children's Hospital, Seoul National University College of Medicine)
  • Received : 2019.02.15
  • Accepted : 2019.06.22
  • Published : 2019.08.15
Download PDF
⟨ Previous Next ⟩

Abstract

Epidemiologic studies of Kawasaki disease (KD) have shown a new pattern or change of its occurrence suggestive of its pathophysiology or risk factors from the first patient with KD reported in 1961. The incidence of KD in Northeast Asian countries including Japan, South Korea, China, and Taiwan is 10-30 times higher than that in the United States and Europe. Knowing the true epidemiology of KD in each country and the availability of publications of KD epidemiology also could benefit general health care providers and general population. This would enable the early detection and treatment of KD, ultimately reducing the incidence of coronary artery complications and mortality. Therefore, efforts to investigate the true epidemiology of KD should be continued in every country using a questionnaire survey, National Health Insurance system data, or combined methods depending on each country's medical environment to ensure high-quality care of patients with KD.

Keywords

References

  1. Wood LE, Tulloh RM. Kawasaki disease in children. Heart 2009;95: 787-92. https://doi.org/10.1136/hrt.2008.143669
  2. McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M, et al. Diagnosis, treatment, and long-term management of kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation 2017;135:e927-99. https://doi.org/10.1161/CIR.0000000000000484
  3. Newburger JW, Takahashi M, Burns JC. Kawasaki disease. J Am Coll Cardiol 2016;67:1738-49. https://doi.org/10.1016/j.jacc.2015.12.073
  4. Singh S, Vignesh P, Burgner D. The epidemiology of Kawasaki disease: a global update. Arch Dis Child 2015;100:1084-8. https://doi.org/10.1136/archdischild-2014-307536
  5. Daniels LB, Tjajadi MS, Walford HH, Jimenez-Fernandez S, Trofimenko V, Fick DB Jr, et al. Prevalence of Kawasaki disease in young adults with suspected myocardial ischemia. Circulation 2012;125: 2447-53. https://doi.org/10.1161/CIRCULATIONAHA.111.082107
  6. Kawasaki T. [Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children]. Arerugi 1967;16:178-222.
  7. Nakamura Y. Kawasaki disease: epidemiology and the lessons from it. Int J Rheum Dis 2018;21:16-9. https://doi.org/10.1111/1756-185X.13211
  8. Kim GB, Park S, Eun LY, Han JW, Lee SY, Yoon KL, et al. Epidemiology and clinical features of Kawasaki disease in South Korea, 2012-2014. Pediatr Infect Dis J 2017;36:482-5. https://doi.org/10.1097/INF.0000000000001474
  9. Makino N, Nakamura Y, Yashiro M, Sano T, Ae R, Kosami K, et al. Epidemiological observations of Kawasaki disease in Japan, 2013-2014. Pediatr Int 2018;60:581-7. https://doi.org/10.1111/ped.13544
  10. Makino N, Nakamura Y, Yashiro M, Ae R, Tsuboi S, Aoyama Y, et al. Descriptive epidemiology of Kawasaki disease in Japan, 2011-2012: from the results of the 22nd nationwide survey. J Epidemiol 2015; 25:239-45. https://doi.org/10.2188/jea.JE20140089
  11. Kim GB, Han JW, Park YW, Song MS, Hong YM, Cha SH, et al. Epidemiologic features of Kawasaki disease in South Korea: data from nationwide survey, 2009-2011. Pediatr Infect Dis J 2014;33:24-7. https://doi.org/10.1097/INF.0000000000000010
  12. Lin MT, Wu MH. The global epidemiology of Kawasaki disease: review and future perspectives. Glob Cardiol Sci Pract 2017;2017: e201720. https://doi.org/10.21542/gcsp.2017.20
  13. Ha S, Seo GH, Kim KY, Kim DS. Epidemiologic study on Kawasaki disease in Korea, 2007-2014: based on Health Insurance Review & Assessment Service Claims. J Korean Med Sci 2016;31:1445-9. https://doi.org/10.3346/jkms.2016.31.9.1445
  14. Huang WC, Huang LM, Chang IS, Chang LY, Chiang BL, Chen PJ, et al. Epidemiologic features of Kawasaki disease in Taiwan, 2003-2006. Pediatrics 2009;123:e401-5. https://doi.org/10.1542/peds.2008-2187
  15. Lin MC, Lai MS, Jan SL, Fu YC. Epidemiologic features of Kawasaki disease in acute stages in Taiwan, 1997-2010: effect of different case definitions in claims data analysis. J Chin Med Assoc 2015;78:121-6. https://doi.org/10.1016/j.jcma.2014.03.009
  16. Uehara R, Belay ED. Epidemiology of Kawasaki disease in Asia, Europe, and the United States. J Epidemiol 2012;22:79-85. https://doi.org/10.2188/jea.JE20110131
  17. Chen JJ, Ma XJ, Liu F, Yan WL, Huang MR, Huang M, et al. Epidemiologic features of Kawasaki disease in Shanghai from 2008 through 2012. Pediatr Infect Dis J 2016;35:7-12. https://doi.org/10.1097/INF.0000000000000914
  18. Manlhiot C, O'Shea S, Bernknopf B, LaBelle M, Chahal N, Dillenburg RF, et al. Epidemiology of Kawasaki disease in Canada 2004 to 2014: comparison of Surveillance Using Administrative Data vs Periodic Medical Record Review. Can J Cardiol 2018;34:303-9. https://doi.org/10.1016/j.cjca.2017.12.009
  19. Holman RC, Belay ED, Christensen KY, Folkema AM, Steiner CA, Schonberger LB. Hospitalizations for Kawasaki syndrome among children in the United States, 1997-2007. Pediatr Infect Dis J 2010;29: 483-8. https://doi.org/10.1097/inf.0b013e3181cf8705
  20. Mauro A, Fabi M, Da Fre M, Guastaroba P, Corinaldesi E, Calabri GB, et al. Kawasaki disease: an epidemiological study in central Italy. Pediatr Rheumatol Online J 2016;14:22. https://doi.org/10.1186/s12969-016-0084-6
  21. Salo E, Griffiths EP, Farstad T, Schiller B, Nakamura Y, Yashiro M, et al. Incidence of Kawasaki disease in northern European countries. Pediatr Int 2012;54:770-2. https://doi.org/10.1111/j.1442-200X.2012.03692.x
  22. Sanchez-Manubens J, Anton J, Bou R, Iglesias E, Calzada-Hernandez J; Kawasaki Disease in Catalonia Working Group. Incidence, epidemiology and clinical features of Kawasaki disease in Catalonia, Spain. Clin Exp Rheumatol 2016;34(3 Suppl 97):S139-44.
  23. Garcia Rodriguez F, Flores Pineda AJ, Villarreal Trevino AV, Salinas Encinas DR, Lara Herrera PB, Maldonado Velazquez MDR, et al. Kawasaki disease at a pediatric hospital in Mexico. Bol Med Hosp Infant Mex 2016;73:166-73.
  24. Hoyos-Bachiloglu R, Garcia A, Morales PS, Cerda J, Talesnik E, Borzutzky A. Geographic distribution of Kawasaki disease throughout Chile. Rev Chilena Infectol 2016;33:12-8. https://doi.org/10.4067/S0716-10182016000100002
  25. Ulloa-Gutierrez R, Salgado AP, Tremoulet AH. Kawasaki disease in Latin American children: past, current, and future challenges. J Pediatric Infect Dis Soc 2014;3:280-1. https://doi.org/10.1093/jpids/piu105
  26. Kim GB, Park S, Kwon BS, Han JW, Park YW, Hong YM. Evaluation of the temporal association between Kawasaki disease and viral infections in South Korea. Korean Circ J 2014;44:250-4. https://doi.org/10.4070/kcj.2014.44.4.250
  27. Nakamura Y, Yashiro M, Uehara R, Oki I, Watanabe M, Yanagawa H. Monthly observation of the number of patients with Kawasaki disease and its incidence rates in Japan: chronological and geographical observation from nationwide surveys. J Epidemiol 2008;18:273-9. https://doi.org/10.2188/jea.JE2008030
  28. Son MBF, Newburger JW. Kawasaki disease. Pediatr Rev 2018;39:78-90. https://doi.org/10.1542/pir.2016-0182
  29. Zhang X, Liang Y, Feng W, Su X, Zhu H. Epidemiologic survey of Kawasaki disease in Inner Mongolia, China, between 2001 and 2013. Exp Ther Med 2016;12:1220-4. https://doi.org/10.3892/etm.2016.3393
  30. Cimaz R, Fanti E, Mauro A, Voller F, Rusconi F. Epidemiology of Kawasaki disease in Italy: surveillance from national hospitalization records. Eur J Pediatr 2017;176:1061-5. https://doi.org/10.1007/s00431-017-2947-3
  31. Saundankar J, Yim D, Itotoh B, Payne R, Maslin K, Jape G, et al. The epidemiology and clinical features of Kawasaki disease in Australia. Pediatrics 2014;133:e1009-14. https://doi.org/10.1542/peds.2013-2936
  32. Tulloh RMR, Mayon-White R, Harnden A, Ramanan AV, Tizard EJ, Shingadia D, et al. Kawasaki disease: a prospective population survey in the UK and Ireland from 2013 to 2015. Arch Dis Child 2019;104: 640-6. https://doi.org/10.1136/archdischild-2018-315087
  33. Jakob A, Whelan J, Kordecki M, Berner R, Stiller B, Arnold R, et al. Kawasaki disease in Germany: a prospective, population-based study adjusted for underreporting. Pediatr Infect Dis J 2016;35:129-34. https://doi.org/10.1097/INF.0000000000000953
  34. Shoham AB, Haklai Z, Dor M, Bar-Meir M. Rheumatic fever and Kawasaki disease among children in Israel. Harefuah 2014;153:709-12,
  35. Durongpisitkul K, Sangtawesin C, Khongphatthanayopthin A, Panamonta M, Sopontammarak S, Sittiwangkul R, et al. Epidemiologic study of Kawasaki disease and cases resistant to IVIG therapy in Thailand. Asian Pac J Allergy Immunol 2006;24:27-32.
  36. Pinto FF, Laranjo S, Mota Carmo M, Brito MJ, Cruz Ferreira R. Twelve years of Kawasaki disease in Portugal: epidemiology in hospitalized children. Pediatr Infect Dis J 2017;36:364-8. https://doi.org/10.1097/INF.0000000000001444
  37. Tacke CE, Breunis WB, Pereira RR, Breur JM, Kuipers IM, Kuijpers TW. Five years of Kawasaki disease in the Netherlands: a national surveillance study. Pediatr Infect Dis J 2014;33:793-7. https://doi.org/10.1097/INF.0000000000000271

Cited by

  1. Can the accurate epidemiological study help to search the etiology of Kawasaki disease? vol.63, pp.3, 2019, https://doi.org/10.3345/kjp.2019.00367
  2. Defining Association between COVID-19 and the Multisystem Inflammatory Syndrome in Children through the Pandemic vol.35, pp.22, 2020, https://doi.org/10.3346/jkms.2020.35.e204
  3. Young Children Presenting With Fever and Rash in the Midst of SARS-CoV-2 Outbreak in New York vol.59, pp.12, 2019, https://doi.org/10.1177/0009922820941631
  4. Age-related differences in clinical characteristics of Kawasaki disease vol.54, pp.3, 2021, https://doi.org/10.1590/1414-431x202010281
  5. MicroRNA-223 Regulates the Development of Cardiovascular Lesions in LCWE-Induced Murine Kawasaki Disease Vasculitis by Repressing the NLRP3 Inflammasome vol.9, 2021, https://doi.org/10.3389/fped.2021.662953
  6. Epidemiology of Kawasaki Disease in Europe vol.9, 2021, https://doi.org/10.3389/fped.2021.673554
  7. No temporal association between human coronavirus and Kawasaki disease: National data from South Korea vol.93, pp.2, 2021, https://doi.org/10.1002/jmv.26435
  8. Embryologie, Fehlbildungen und seltene Erkrankungen der Cochlea vol.100, pp.1, 2019, https://doi.org/10.1055/a-1349-3824
  9. Kawasaki disease for the paediatric dermatologist: skin manifestations and new insights into the pathophysiology vol.46, pp.3, 2019, https://doi.org/10.1111/ced.14558
  10. Seasonal Trends of Viral Prevalence and Incidence of Kawasaki Disease: A Korea Public Health Data Analysis vol.10, pp.15, 2021, https://doi.org/10.3390/jcm10153301
  11. Hygiene Hypothesis as the Etiology of Kawasaki Disease: Dysregulation of Early B Cell Development vol.22, pp.22, 2021, https://doi.org/10.3390/ijms222212334
  12. The occurrence of coronary artery lesions in Kawasaki disease based on C-reactive protein levels: a retrospective cohort study vol.19, pp.1, 2019, https://doi.org/10.1186/s12969-021-00566-6